FDA offers drugmakers advice on new obesity drugs
281926
As more Americans struggle with growing waistlines, U.S. health officials on Wednesday set out their own tips for drugmakers seeking to develop products for people trying to shed pounds.
362519
Health regulators on Friday issued draft guidance that would make it easier for pharmaceutical companies to advise doctors about unapproved uses for their medicines.
672501
NEW YORK  - A drug approved for the treatment of arthritis may have a role in reducing the risk of diabetes and heart trouble developing in young obese individuals, Harvard researchers report.
467561
Dec. 23, 2004 - The Food and Drug Administration today issued a Public Health Advisory summarizing the agency&#39;s recent cautions and recommendations concerning the use of non-steroidal anti-inflammatory drug
386658
The U.S. Food and Drug Administration is facing new questions about its ability to police the safety of medicines after they reach the market following concerns about a widely used diabetes drug.
367072
U.S. drug regulators on Wednesday will issue a public health advisory about the potential risks of a pain drug made by Cephalon Inc, an agency official said.
393977
The U.S. Food and Drug Administration said on Tuesday it would make organizational changes to improve internal communication about potential risks that emerge after a new drug reaches the market.
223061
Drug companies could soon make more experimental drugs available for a fee to more patients with serious or life-threatening diseases that have no approved treatments, under revised rules the U.S. Food and Drug Administration proposed on Monday.
230283
With Vioxx off the market because of links to heart problems and concerns growing about the related drugs Celebrex and Bextra, a pair of Food and Drug Administration advisory committees are assessing the safety of the popular painkillers.
752198
Drug companies are racing to capture the ballooning market in diabetes care. Pfizer Inc. plans to debut Exubra, its new inhaled insulin treatment, in July, and Merck &amp; Co., Novartis AG and Eli Lilly and Co. are awaiting FDA approval for new diabetes products that could generate hundreds of millions of dollars in sales.
565009
Some of the health benefits claimed for a new weight loss drug may not be justified, say experts.
150048
The Food and Drug Administration will establish a new independent Drug Safety Oversight Board to monitor FDA-approved medicines once they're on the market and update physicians and patients with emerging information on risks and benefits.
639313
Six physicians with financial ties to Johnson &amp; Johnson and other heart-device makers will be advising US regulators whether to restrict the use of some products because of potentially lethal side effects.
280625
U.S. regulators said on Friday they would review whether to take action over Merck & Co Inc's and Schering-Plough Corp's popular cholesterol medicine Vytorin after a study showed it was no better than a generic drug in preventing the build-up of fatty plaque.
422559
U.S. drug regulators on Wednesday will issue a public health advisory about the potential risks of a pain drug made by Cephalon Inc, an FDA official said.
211731
The Food and Drug Administration on Thursday ordered a review of all prevention studies involving drugs such as Celebrex and Bextra, which have been associated with increased risk of heart problems. The agency also urged the public to limit use of over-the-counter pain medications.
210819
The Food and Drug Administration issued a public health advisory Thursday, recommending doctors limit the use of Pfizer Inc.&#39;s Celebrex and Bextra to patients who can&#39;t take other pain medicines.